Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer

BACKGROUND AND METHODS: Inflammation is a hallmark of cancer and its progression. Plasma levels of C‐reactive protein (CRP), interleukin‐6 (IL‐6) and YKL‐40 reflect inflammation, and are elevated in patients with cancer. This study investigated whether plasma CRP, IL‐6 and YKL‐40 had diagnostic valu...

Descripción completa

Detalles Bibliográficos
Autores principales: Videmark, Alex N., Christensen, Ib J., Feltoft, Claus L., Villadsen, Mette, Borg, Frederikke H., Jørgensen, Barbara M., Bojesen, Stig E., Kistorp, Caroline, Ugleholdt, Randi, Johansen, Julia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067028/
https://www.ncbi.nlm.nih.gov/pubmed/36440611
http://dx.doi.org/10.1002/cam4.5455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067028/
https://www.ncbi.nlm.nih.gov/pubmed/36440611
http://dx.doi.org/10.1002/cam4.5455

Ejemplares similares